Publications by authors named "George Cusatis"

Claim this Profile
S
Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer.
Colin D Weekes, Dongweon Song, John Arcaroli, Lora A Wilson, Belen Rubio-Viqueira, George Cusatis

Neoplasia· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomic importance of ABCG2.
George Cusatis, Alex Sparreboom

Pharmacogenomics· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors.
Antonio Jimeno, Najat C Daw, Maria L Amador, George Cusatis, Peter Kulesza

Pediatr Blood Cancer· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of two novel benzoylphenylurea sulfur analogues and evidence that the microtubule-associated protein tau is predictive of their activity in pancreatic cancer.
Antonio Jimeno, Gurulingappa Hallur, Audrey Chan, Xiangfeng Zhang, George Cusatis

Mol Cancer Ther· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients.
Jing Li, George Cusatis, Julie Brahmer, Alex Sparreboom, Robert W Robey

Cancer Biol Ther· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics of ABCG2 and adverse reactions to gefitinib.
George Cusatis, Vanesa Gregorc, Jing Li, Anna Spreafico, Roxann G Ingersoll

J Natl Cancer Inst· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An in vivo platform for translational drug development in pancreatic cancer.
Belen Rubio-Viqueira, Antonio Jimeno, George Cusatis, Xianfeng Zhang, Christine Iacobuzio-Donahue

Clin Cancer Res· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients.
Erin R Lepper, Sharyn D Baker, Matt Permenter, Nicole Ries, Ron H N van Schaik, George Cusatis

Clin Cancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors.
Maria L Amador, Darin Oppenheimer, Sofia Perea, Anirban Maitra, George Cusatis

Cancer Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis